GGrantIndex
← Leaderboards

Joel N. Kline

University Of Iowa

$5,822,595
Attributed
$5,822,595
Total exposure
16
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY200511
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11

Funding mix

By agency

NIH$5,822,595 · 16

By mechanism

R01$2,373,939 · 2
P30$1,618,440 · 5
M01$945,216 · 7
R21$885,000 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of Iowa

Same institution · by research overlap

Others in their field

Top investigators on “Environmental Exposure

Research focus

Environmental ExposureAsthmaInflammationAgricultureClinical ResearchHuman SubjectLaboratory MouseTrainingInvestigationCpg IslandsResponseResourcesEnvironmental HealthImmune Tolerance /UnresponsivenessRuralHelper T LymphocyteLungAerosolsImageLeukocyte Activation /TransformationBronchoscopyCellular ImmunityLung DiseasesSampling

Grant awards (40)

Precise Correspondence of 3D Pathology with Radiological Features in Lung Nodules$336,695
R01 · FY2011 · CA · contact PI
Precise Correspondence of 3D Pathology with Radiological Features in Lung Nodules$350,135
R01 · FY2010 · CA · contact PI
Facility Core A--Integrative Health Sciences$280,038
P30 · FY2010 · ES · contact PI
Inflammation and Innate Immunity Research Cluster$31,284
P30 · FY2010 · ES · contact PI
Facility Core A--Integrative Health Sciences$282,049
P30 · FY2009 · ES · contact PI
Inflammation and Innate Immunity Research Cluster$31,585
P30 · FY2009 · ES · contact PI
Facility Core A--Integrative Health Sciences$296,093
P30 · FY2008 · ES · contact PI
Inflammation and Innate Immunity Research Cluster$33,177
P30 · FY2008 · ES · contact PI
Facility Core A--Integrative Health Sciences$258,036
P30 · FY2007 · ES · contact PI
Inflammation and Innate Immunity Research Cluster$28,864
P30 · FY2007 · ES · contact PI
CORTICOSTEROID REDUCTION IN ASTHMA AND THE BRAIN (CRAB) PILOT PROJECT$2,443
M01 · FY2007 · RR · contact PI
Induction of Respiratory Tolerance By Mucosal CpG ODN$324,077
R01 · FY2006 · HL · contact PI
Facility C: Clinical Exposure$103,044
P30 · FY2006 · ES · contact PI
Project 2: Pulmonary Biology$24,320
P30 · FY2006 · ES · contact PI
DETERMINANTS OF RESPONSE TO INHALED IRRITANT IN ASTHMA$23,161
M01 · FY2006 · RR · contact PI
ROLE OF CPG MOTIFS IN PLASMID DNA AS A BARRIER TO GENE TRANSFER$331
M01 · FY2006 · RR · contact PI
Induction of Respiratory Tolerance By Mucosal CpG ODN$331,875
R01 · FY2005 · HL
Early Life Exposure to Microbial Products and Asthma$221,250
R21 · FY2005 · HL
Helminth-Induced Immune Tolerance in Asthma$221,250
R21 · FY2005 · HL
Facility C: Clinical Exposure$102,208
P30 · FY2005 · ES
ALLERGEN IMMUNOTHERAPY CO-ADMINISTERED WITH OMALIZUMAB, AN ANTI-IGE MAB$89,030
M01 · FY2005 · RR
DETERMINANTS OF RESPONSE TO INHALED IRRITANT IN ASTHMA$60,864
M01 · FY2005 · RR
Project 2: Pulmonary Biology$23,650
P30 · FY2005 · ES
ROLE OF CPG MOTIFS IN PLASMID DNA AS A BARRIER TO GENE TRANSFER$323
M01 · FY2005 · RR
Allergen Immunotherapy Co-Administered with Omalizumab$370,029
M01 · FY2004 · RR
Induction of Respiratory Tolerance By Mucosal CpG ODN$331,875
R01 · FY2004 · HL
Helminth-Induced Immune Tolerance in Asthma$221,250
R21 · FY2004 · HL
Early Life Exposure to Microbial Products and Asthma$221,250
R21 · FY2004 · HL
Facility C: Clinical Exposure$101,091
P30 · FY2004 · ES
Project 2: Pulmonary Biology$23,001
P30 · FY2004 · ES
Determinants of Response to Inhaled Irritant in Asthma$21,251
M01 · FY2004 · RR
Induction of Respiratory Tolerance By Mucosal CpG ODN$331,782
R01 · FY2003 · HL
CPG MOTIFS IN PLASMID DNA AS BARRIER TO GENE TRANSFER$177,878
M01 · FY2002 · RR
MODULATION OF EOSINOPHILIC LUNG INFLAMATION BY CPG DNA$110,250
R01 · FY2002 · HL
Core--Clinical Exposure$0
P30 · FY2002 · ES
CPG MOTIFS IN PLASMID DNA AS BARRIER TO GENE TRANSFER$177,878
M01 · FY2001 · RR
MODULATION OF EOSINOPHILIC LUNG INFLAMATION BY CPG DNA$110,250
R01 · FY2001 · HL
Core--Clinical Exposure$0
P30 · FY2001 · ES
MODULATION OF EOSINOPHILIC LUNG INFLAMATION BY CPG DNA$147,000
R01 · FY2000 · HL
CPG MOTIFS IN PLASMID DNA AS BARRIER TO GENE TRANSFER$22,028
M01 · FY2000 · RR